{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:43:24Z","timestamp":1777502604313,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T00:00:00Z","timestamp":1720224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T00:00:00Z","timestamp":1720224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Department of Science and Technology","award":["DST\/INSPIRE Fellowship\/2019\/IF190083"],"award-info":[{"award-number":["DST\/INSPIRE Fellowship\/2019\/IF190083"]}]},{"DOI":"10.13039\/501100008762","name":"Tamil Nadu State Council for Higher Education","doi-asserted-by":"publisher","award":["RGP\/2019-20\/ALU\/HECP-0049"],"award-info":[{"award-number":["RGP\/2019-20\/ALU\/HECP-0049"]}],"id":[{"id":"10.13039\/501100008762","id-type":"DOI","asserted-by":"publisher"}]},{"name":"DST-Promotion of University Research and Scientific Excellence","award":["No. SR\/PURSE Phase 2\/38(G)"],"award-info":[{"award-number":["No. SR\/PURSE Phase 2\/38(G)"]}]},{"name":"DST-Fund for Improvement of S &T Infrastructure in Universities  Higher Educational Institutions","award":["SR\/FST\/LSI-667\/2016) (C)"],"award-info":[{"award-number":["SR\/FST\/LSI-667\/2016) (C)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s11030-024-10910-z","type":"journal-article","created":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T05:01:26Z","timestamp":1720242086000},"page":"1287-1303","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Computational discovery of AKT serine\/threonine kinase 1 inhibitors through shape screening for rheumatoid arthritis intervention"],"prefix":"10.1007","volume":"29","author":[{"given":"Raghu","family":"Rangaswamy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subramaniyan","family":"Sneha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagarajan","family":"Hemavathy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vetrivel","family":"Umashankar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeyaraman","family":"Jeyakanthan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,6]]},"reference":[{"key":"10910_CR1","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB (2016) Rheumatoid arthritis. Lancet 388:2023\u20132038. https:\/\/doi.org\/10.1016\/S0140-6736(16)30173-8","journal-title":"Lancet"},{"key":"10910_CR2","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/nejmra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365:2205\u20132219. https:\/\/doi.org\/10.1056\/nejmra1004965","journal-title":"N Engl J Med"},{"key":"10910_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41413-018-0016-9","volume":"6","author":"Q Guo","year":"2018","unstructured":"Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J (2018) Rheumatoid arthritis: Pathological mechanisms and modern pharmacologic therapies. Bone Res 6:15. https:\/\/doi.org\/10.1038\/s41413-018-0016-9","journal-title":"Bone Res"},{"key":"10910_CR4","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1159\/000493390","volume":"27","author":"J Bullock","year":"2018","unstructured":"Bullock J, Rizvi SAA, Saleh AM, Ahmed SS, Do DP, Ansari RA, Ahmed J (2018) Rheumatoid arthritis: a brief overview of the treatment. Med Princ Pract 27:501\u2013507. https:\/\/doi.org\/10.1159\/000493390","journal-title":"Med Princ Pract"},{"key":"10910_CR5","doi-asserted-by":"publisher","first-page":"680043","DOI":"10.3389\/fphar.2021.680043","volume":"12","author":"S Shams","year":"2021","unstructured":"Shams S, Martinez JM, Dawson JRD, Flores J, Gabriel M, Garcia G et al (2021) The therapeutic landscape of rheumatoid arthritis: current state and future directions. Front Pharmacol 12:680043. https:\/\/doi.org\/10.3389\/fphar.2021.680043","journal-title":"Front Pharmacol"},{"key":"10910_CR6","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.4155\/fmc.15.55","volume":"7","author":"CJ Malemud","year":"2015","unstructured":"Malemud CJ (2015) The PI3K\/Akt\/PTEN\/mTOR pathway: a fruitful target for inducing cell death in rheumatoid arthritis? Future Med Chem 7:1137\u20131147. https:\/\/doi.org\/10.4155\/fmc.15.55","journal-title":"Future Med Chem"},{"key":"10910_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cca.2006.06.033","volume":"375","author":"CJ Malemud","year":"2007","unstructured":"Malemud CJ (2007) Growth hormone, VEGF and FGF: Involvement in rheumatoid arthritis. Clin Chim Acta 375:10\u201319. https:\/\/doi.org\/10.1016\/j.cca.2006.06.033","journal-title":"Clin Chim Acta"},{"key":"10910_CR8","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.clim.2012.09.009","volume":"148","author":"A Markopoulou","year":"2013","unstructured":"Markopoulou A, Kyttaris VC (2013) Small molecules in the treatment of systemic lupus erythematosus. Clin Immunol 148:359\u2013368. https:\/\/doi.org\/10.1016\/j.clim.2012.09.009","journal-title":"Clin Immunol"},{"key":"10910_CR9","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","volume":"233","author":"B Bartok","year":"2010","unstructured":"Bartok B, Firestein GS (2010) Fibroblast-like synoviocytes: Key effector cells in rheumatoid arthritis. Immunol Rev 233:233\u2013255. https:\/\/doi.org\/10.1111\/j.0105-2896.2009.00859.x","journal-title":"Immunol Rev"},{"key":"10910_CR10","doi-asserted-by":"publisher","first-page":"R33","DOI":"10.1186\/ar2941","volume":"12","author":"S Garc\u00eda","year":"2010","unstructured":"Garc\u00eda S, Liz M, G\u00f3mez-Reino JJ, Conde C (2010) Akt activity protects rheumatoid synovial fibroblasts from Fas-induced apoptosis by inhibition of Bid cleavage. Arthritis Res Ther 12:R33. https:\/\/doi.org\/10.1186\/ar2941","journal-title":"Arthritis Res Ther"},{"key":"10910_CR11","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.2042-7158.1998.tb06874.x","volume":"50","author":"IC Chikanza","year":"1998","unstructured":"Chikanza IC, Jawed S, Naughton D, Blake DR (1998) Why do we need new treatments for rheumatoid arthritis? J Pharm Pharmacol 50:357\u2013369. https:\/\/doi.org\/10.1111\/j.2042-7158.1998.tb06874.x","journal-title":"J Pharm Pharmacol"},{"key":"10910_CR12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/19336918.2015.1016686","volume":"9","author":"W Xu","year":"2015","unstructured":"Xu W, Yang Z, Lu N (2015) A new role for the PI3K\/Akt signaling pathway in the epithelial-mesenchymal transition. Cell Adh Migr 9:317\u2013324. https:\/\/doi.org\/10.1080\/19336918.2015.1016686","journal-title":"Cell Adh Migr"},{"key":"10910_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11081362","author":"RT Meehan","year":"2021","unstructured":"Meehan RT, Amigues IA, Knight V (2021) Precision medicine for rheumatoid arthritis: the right drug for the right patient-companion diagnostics. Diagnostics (Basel). https:\/\/doi.org\/10.3390\/diagnostics11081362","journal-title":"Diagnostics (Basel)"},{"key":"10910_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/cells9081876","author":"M Massalska","year":"2020","unstructured":"Massalska M, Maslinski W, Ciechomska M (2020) Small molecule inhibitors in the treatment of rheumatoid arthritis and beyond: latest updates and potential strategy for fighting COVID-19. Cells. https:\/\/doi.org\/10.3390\/cells9081876","journal-title":"Cells"},{"key":"10910_CR15","unstructured":"Benjamin O, Goyal A, Lappin SL (2022) StatPearls: Disease Modifying Anti-Rheumatic Drugs (DMARD). Treasure Island (FL)."},{"key":"10910_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/biom10071002","author":"J Angelini","year":"2020","unstructured":"Angelini J, Talotta R, Roncato R, Fornasier G, Barbiero G, Dal Cin L et al (2020) JAK-inhibitors for the treatment of rheumatoid arthritis: a focus on the present and an outlook on the future. Biomolecules. https:\/\/doi.org\/10.3390\/biom10071002","journal-title":"Biomolecules"},{"key":"10910_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1177\/1759720X16654476","volume":"8","author":"F Espinoza","year":"2016","unstructured":"Espinoza F, Fabre S, Pers Y-M (2016) Remission-induction therapies for early rheumatoid arthritis: evidence to date and clinical implications. Ther Adv Musculoskelet Dis 8:107\u2013118. https:\/\/doi.org\/10.1177\/1759720X16654476","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10910_CR18","doi-asserted-by":"publisher","unstructured":"L\u00f8ppenthin K, Esbensen BA, \u00d8stergaard M, Ibsen R, Kjellberg J, Jennum P (2019) Morbidity and mortality in patients with rheumatoid arthritis compared. J Comorb. 9:2235042X19853484. https:\/\/doi.org\/10.1177\/2235042X19853484","DOI":"10.1177\/2235042X19853484"},{"key":"10910_CR19","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2018.13103","volume":"320","author":"D Aletaha","year":"2018","unstructured":"Aletaha D, Smolen JS (2018) Diagnosis and management of rheumatoid arthritis: a review. JAMA 320:1360\u20131372. https:\/\/doi.org\/10.1001\/jama.2018.13103","journal-title":"JAMA"},{"key":"10910_CR20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1177\/1759720X17720366","volume":"9","author":"S Ajeganova","year":"2017","unstructured":"Ajeganova S, Huizinga T (2017) Sustained remission in rheumatoid arthritis: Latest evidence and clinical considerations. Ther Adv Musculoskelet Dis 9:249\u2013262. https:\/\/doi.org\/10.1177\/1759720X17720366","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10910_CR21","doi-asserted-by":"crossref","unstructured":"Voegtli WC, Wu W-I, Lord-Ondash HA, Dizon FP, Vigers GPA, Brandhuber BJ. Crystal Structure of Human AKT1 with an Allosteric Inhibitor; 2010.","DOI":"10.2210\/pdb3o96\/pdb"},{"key":"10910_CR22","doi-asserted-by":"publisher","unstructured":"Eswar N, Webb B, Marti-Renom MA, Madhusudhan MS, Eramian D, Shen M-Y, et al. (2006) Comparative protein structure modeling using Modeller. Curr Protoc Bioinformatics. Chapter 5:Unit-5.6. https:\/\/doi.org\/10.1002\/0471250953.bi0506s15","DOI":"10.1002\/0471250953.bi0506s15"},{"key":"10910_CR23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1107\/S0021889892009944","volume":"26","author":"RA Laskowski","year":"1993","unstructured":"Laskowski RA, MacArthur MW, Moss DS, Thornton JM (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 26:283\u2013291. https:\/\/doi.org\/10.1107\/S0021889892009944","journal-title":"J Appl Crystallogr"},{"key":"10910_CR24","doi-asserted-by":"publisher","unstructured":"Bowers KJ, Sacerdoti FD, Salmon JK, Shan Y, Shaw DE, Chow E, et al. (2006) Molecular dynamics---Scalable algorithms for molecular dynamics simulations on commodity clusters. In: Horner-Miller B, editor. the 2006 ACM\/IEEE conference; 11\u201311\u20132006\u201317\u201311\u20132006; Tampa, Florida. New York, New York, USA: ACM Press; p.\u00a084. https:\/\/doi.org\/10.1145\/1188455.1188544.","DOI":"10.1145\/1188455.1188544"},{"key":"10910_CR25","doi-asserted-by":"publisher","first-page":"8577","DOI":"10.1063\/1.470117","volume":"103","author":"U Essmann","year":"1995","unstructured":"Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG (1995) A smooth particle mesh Ewald method. J Chem Phys 103:8577\u20138593. https:\/\/doi.org\/10.1063\/1.470117","journal-title":"J Chem Phys"},{"key":"10910_CR26","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1111\/febs.15112","volume":"287","author":"M Zhang","year":"2020","unstructured":"Zhang M, Ma X, Xu H, Wu W, He X, Wang X et al (2020) A natural AKT inhibitor swertiamarin targets AKT-PH domain, inhibits downstream signaling, and alleviates inflammation. FEBS J 287:1816\u20131829. https:\/\/doi.org\/10.1111\/febs.15112","journal-title":"FEBS J"},{"key":"10910_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ejps.2014.02.005","volume":"56","author":"S Saravanan","year":"2014","unstructured":"Saravanan S, Islam VIH, Babu NP, Pandikumar P, Thirugnanasambantham K, Chellappandian M et al (2014) Swertiamarin attenuates inflammation mediators via modulating NF-\u03baB\/I \u03baB and JAK2\/STAT3 transcription factors in adjuvant induced arthritis. Eur J Pharm Sci 56:70\u201386. https:\/\/doi.org\/10.1016\/j.ejps.2014.02.005","journal-title":"Eur J Pharm Sci"},{"key":"10910_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4196\/kjpp.2019.23.1.21","volume":"23","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, Chen K, Wu T, Song H (2019) Swertiamarin ameliorates carbon tetrachloride-induced hepatic apoptosis via blocking the PI3K\/Akt pathway in rats. Korean J Physiol Pharmacol 23:21\u201328. https:\/\/doi.org\/10.4196\/kjpp.2019.23.1.21","journal-title":"Korean J Physiol Pharmacol"},{"key":"10910_CR29","doi-asserted-by":"publisher","first-page":"358673","DOI":"10.1155\/2013\/358673","volume":"2013","author":"TP Patel","year":"2013","unstructured":"Patel TP, Soni S, Parikh P, Gosai J, Chruvattil R, Gupta S (2013) Swertiamarin: An active lead from enicostemma littorale regulates hepatic and adipose tissue gene expression by targeting PPAR- \u03b3 and improves insulin sensitivity in experimental NIDDM rat model. Evid Based Complement Alternat Med 2013:358673. https:\/\/doi.org\/10.1155\/2013\/358673","journal-title":"Evid Based Complement Alternat Med"},{"key":"10910_CR30","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.biopha.2016.07.028","volume":"83","author":"TP Patel","year":"2016","unstructured":"Patel TP, Rawal K, Soni S, Gupta S (2016) Swertiamarin ameliorates oleic acid induced lipid accumulation and oxidative stress by attenuating gluconeogenesis and lipogenesis in hepatic steatosis. Biomed Pharmacother 83:785\u2013791. https:\/\/doi.org\/10.1016\/j.biopha.2016.07.028","journal-title":"Biomed Pharmacother"},{"key":"10910_CR31","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.fitote.2011.04.008","volume":"82","author":"Y Kimura","year":"2011","unstructured":"Kimura Y, Sumiyoshi M (2011) Effects of Swertia japonica extract and its main compound swertiamarin on gastric emptying and gastrointestinal motility in mice. Fitoterapia 82:827\u2013833. https:\/\/doi.org\/10.1016\/j.fitote.2011.04.008","journal-title":"Fitoterapia"},{"key":"10910_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1021\/acsptsci.2c00120","volume":"6","author":"M Sharma","year":"2023","unstructured":"Sharma M, Malim FM, Goswami A, Sharma N, Juvvalapalli SS, Chatterjee S et al (2023) Neuroprotective effect of swertiamarin in a rotenone model of Parkinson\u2019s disease: role of neuroinflammation and alpha-synuclein accumulation. ACS Pharmacol Transl Sci 6:40\u201351. https:\/\/doi.org\/10.1021\/acsptsci.2c00120","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10910_CR33","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1021\/jm050639j","volume":"49","author":"V Kenyon","year":"2006","unstructured":"Kenyon V, Chorny I, Carvajal WJ, Holman TR, Jacobson MP (2006) Novel human lipoxygenase inhibitors discovered using virtual screening with homology models. J Med Chem 49:1356\u20131363. https:\/\/doi.org\/10.1021\/jm050639j","journal-title":"J Med Chem"},{"key":"10910_CR34","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden S, Ryde U (2015) The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov 10:449\u2013461. https:\/\/doi.org\/10.1517\/17460441.2015.1032936","journal-title":"Expert Opin Drug Discov"},{"key":"10910_CR35","doi-asserted-by":"publisher","first-page":"127056","DOI":"10.1186\/s43088-020-00059-7","volume":"9","author":"SV Pattar","year":"2020","unstructured":"Pattar SV, Adhoni SA, Kamanavalli CM, Kumbar SS (2020) In silico molecular docking studies and MM\/GBSA analysis of coumarin-carbonodithioate hybrid derivatives divulge the anticancer potential against breast cancer. Beni-Suef Univ J Basic Appl Sci 9:127056. https:\/\/doi.org\/10.1186\/s43088-020-00059-7","journal-title":"Beni-Suef Univ J Basic Appl Sci"},{"key":"10910_CR36","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10822-023-00499-0","volume":"37","author":"M Taylor","year":"2023","unstructured":"Taylor M, Ho J (2023) MM\/GBSA prediction of relative binding affinities of carbonic anhydrase inhibitors: effect of atomic charges and comparison with Autodock4Zn. J Comput Aided Mol Des 37:167\u2013182. https:\/\/doi.org\/10.1007\/s10822-023-00499-0","journal-title":"J Comput Aided Mol Des"},{"key":"10910_CR37","doi-asserted-by":"publisher","first-page":"7731","DOI":"10.1039\/C3CP00116D","volume":"15","author":"F Godschalk","year":"2013","unstructured":"Godschalk F, Genheden S, S\u00f6derhjelm P, Ryde U (2013) Comparison of MM\/GBSA calculations based on explicit and implicit solvent simulations. Phys Chem Chem Phys 15:7731\u20137739. https:\/\/doi.org\/10.1039\/C3CP00116D","journal-title":"Phys Chem Chem Phys"},{"key":"10910_CR38","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.drudis.2021.12.017","volume":"27","author":"N Ye","year":"2022","unstructured":"Ye N, Yang Z, Liu Y (2022) Applications of density functional theory in COVID-19 drug modeling. Drug Discov Today 27:1411\u20131419. https:\/\/doi.org\/10.1016\/j.drudis.2021.12.017","journal-title":"Drug Discov Today"},{"key":"10910_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17050742","author":"ND Yilmazer","year":"2016","unstructured":"Yilmazer ND, Korth M (2016) Recent progress in treating protein-ligand interactions with quantum-mechanical methods. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms17050742","journal-title":"Int J Mol Sci"},{"key":"10910_CR40","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fchem.2014.00014","volume":"2","author":"H Hirao","year":"2014","unstructured":"Hirao H, Thellamurege N, Zhang X (2014) Applications of density functional theory to iron-containing molecules of bioinorganic interest. Front Chem 2:14. https:\/\/doi.org\/10.3389\/fchem.2014.00014","journal-title":"Front Chem"},{"key":"10910_CR41","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3390\/ijms17040519","volume":"17","author":"SP de Visser","year":"2016","unstructured":"de Visser SP, Stillman MJ (2016) Challenging Density Functional Theory Calculations with Hemes and Porphyrins. Int J Mol Sci 17:519. https:\/\/doi.org\/10.3390\/ijms17040519","journal-title":"Int J Mol Sci"},{"key":"10910_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/molecules21060748","author":"LR Domingo","year":"2016","unstructured":"Domingo LR, R\u00edos-Guti\u00e9rrez M, P\u00e9rez P (2016) Applications of the conceptual density functional theory indices to organic chemistry reactivity. Molecules. https:\/\/doi.org\/10.3390\/molecules21060748","journal-title":"Molecules"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-10910-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-024-10910-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-10910-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T12:41:44Z","timestamp":1741956104000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-024-10910-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,6]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10910"],"URL":"https:\/\/doi.org\/10.1007\/s11030-024-10910-z","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,6]]},"assertion":[{"value":"29 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}